Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational medication designed to help reduce PTSD symptoms.
Post-Traumatic Stress Disorder (PTSD)
Age Range:
18
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
This research study is evaluating TSND-201 (methylone), an investigational medication, to determine whether it may help improve symptoms of PTSD. Researchers will compare the study drug to placebo to assess its effectiveness, safety, and tolerability.
Qualifications
Qualifications
You may be able to join if you:
- Are 18 years of age or older.
- Have been diagnosed with PTSD for at least 6 months.
- Have moderate to severe PTSD symptoms.
- Have previously tried at least one PTSD treatment (medication or therapy).
- Are able to attend all study visits and follow study procedures.
- Are willing to stop certain medications that are not allowed during the study, if medically appropriate.
FEATURED STUDIES
Post-Traumatic Stress Disorder (PTSD)
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Bronchiectasis
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home
Hypertension & Type 2 Diabetes
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for
Idiopathic Hypersomnia Study Interest List
Suburban Research Associates is conducting a clinical research study for adults with Idiopathic Hypersomnia for an upcoming study on daytime
Uncontrolled Hypertension
Adults 18–65 with a history of high blood pressure that remains elevated despite treatment may qualify for a study evaluating
Type 2 Diabetes
Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a